C677T polymorphism of the methylenetetrahydrofolate reductase gene is a risk factor of adverse events after coronary revascularization
- 1 September 2004
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 96 (3) , 341-345
- https://doi.org/10.1016/j.ijcard.2003.06.022
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Can screening for genetic markers improve peripheral artery bypass patency?Journal of Vascular Surgery, 2002
- Association of plasma homocysteine with restenosis after percutaneous coronary angioplastyEuropean Heart Journal, 2002
- Increasing levels of dietary homocystine with carotid endarterectomy produced proportionate increases in plasma homocysteine and intimal hyperplasiaAtherosclerosis, 2001
- Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid depositionHuman Molecular Genetics, 2001
- Increase in Plasma Homocysteine Associated with Parallel Increases in Plasma S-Adenosylhomocysteine and Lymphocyte DNA HypomethylationJournal of Biological Chemistry, 2000
- Homocysteine and atherothrombosis—mechanisms for injuryEuropean Heart Journal, 2000
- Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and the risk of coronary artery diseaseEuropean Journal of Clinical Investigation, 1998
- Correlation of a Common Mutation in the Methylenetetrahydrofolate Reductase Gene With Plasma Homocysteine in Patients With Premature Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991